Literature DB >> 26254747

Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol.

Nancy A Pike1, Carol A Okuhara2, Joy Toyama3, Barbara P Gross2, Winfield J Wells4, Vaughn A Starnes4.   

Abstract

BACKGROUND: Persistent pleural effusions after the Fontan procedure contribute to prolonged hospitalization and increased costs. We report our experience using a modified Wisconsin Fontan protocol to reduce chest tube drainage and hospital length of stay (LOS).
METHODS: Single institutional retrospective chart review of 120 consecutive patients (60 before and 60 after initiation of our protocol) undergoing an extracardiac Fontan procedure from January 2004 to February 2007. Protocol influence was assessed by comparing group differences on duration of pleural drainage, requirement for nothing by mouth/total parenteral nutrition, hospital LOS, readmission for pleural effusion, and total hospital costs.
RESULTS: Groups were similar in demographic characteristics, single ventricle morphology, preoperative hemodynamic parameters, and operative and immediate postoperative management. Median duration of pleural drainage and hospital LOS was reduced in the post- versus preprotocol groups: 4 days (interquartile range [IQR], 4-5 days) pre versus 6 days (IQR, 5-10 days) (P < .0001) and 6 days (IQR, 5-9 days) versus 8 days (IQR, 6-13 days) (P = .005), respectively. Pleural drainage lasting >1 week was also less common postprotocol: 23 (38%) before versus 7 (12%) after (P = .001). Fewer postprotocol patients required nothing by mouth/total parenteral nutrition to control effusions: 5 pre versus 0 post (P = .06), and fewer readmissions for effusions (14 before vs 7 after [P = .1]). An average total cost savings of 22% and readmissions savings of 29% resulted in nearly $500,000 in institutional savings over the study period.
CONCLUSIONS: A modified Fontan protocol resulted in reduced time to chest tube removal, hospital LOS, and chest tube drainage lasting >1 week. There was a strong trend toward avoiding nothing by mouth/total parenteral nutrition to control pleural effusion and lower hospital costs.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fontan; congenital heart disease; pleural effusion; postoperative care; protocol

Mesh:

Year:  2015        PMID: 26254747     DOI: 10.1016/j.jtcvs.2015.06.042

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Early Postoperative Albumin Administration Contributes to Morbidity After the Fontan Operation.

Authors:  Hayden J Zaccagni; Jeffrey A Alten; David C Cleveland; R Tyler Argent; Mark A Law; Ayesha S Bryant; Santiago Borasino
Journal:  Pediatr Cardiol       Date:  2016-06-09       Impact factor: 1.655

2.  Prophylactic Opening of the Pleural Cavity for Postoperative Drainage is a Risk Factor for Prolonged Pleural Effusion After a Fontan Operation.

Authors:  Naoki Masaki; Mizumoto Masahiro; Satoshi Matsuo; Sadahiro Sai
Journal:  Pediatr Cardiol       Date:  2019-08-29       Impact factor: 1.655

3.  Risk Factors for Prolonged Pleural Effusion After Extracardiac Fontan Operation.

Authors:  Geena Kim; Hoon Ko; Joung-Hee Byun; Hyoung Doo Lee; Hyungtae Kim; Si Chan Sung; Kwang Ho Choi
Journal:  Pediatr Cardiol       Date:  2019-08-21       Impact factor: 1.655

4.  Unplanned hospital readmissions following congenital heart diseases surgery. Prevalence and predictors.

Authors:  Ahmad S Azhar
Journal:  Saudi Med J       Date:  2019-08       Impact factor: 1.484

5.  Standardization of Care Reduces Length of Stay for Postoperative Congenital Heart Disease Patients.

Authors:  Tara C Cosgrove; Lauren N Carlozzi; Kevin F Dolan; Sean P Gleeson; Lanette L Johnson; Steven C Cassidy; Robert J Gajarski
Journal:  Pediatr Qual Saf       Date:  2021-12-15

6.  Risk Factors for Prolonged Pleural Effusion Following Total Cavopulmonary Connection Surgery: 9 Years' Experience at Fuwai Hospital.

Authors:  Qipeng Luo; Wei Zhao; Zhanhao Su; Yiwei Liu; Yuan Jia; Liang Zhang; Hongbai Wang; Yinan Li; Xie Wu; Shoujun Li; Fuxia Yan
Journal:  Front Pediatr       Date:  2019-11-07       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.